Ras
Les protéines Ras sont de petites GTPases qui agissent comme des commutateurs moléculaires dans la voie de signalisation MAPK, contrôlant la croissance, la différenciation et la survie cellulaires. Ras activé initie une cascade de signalisation qui inclut Raf, MEK et ERK, conduisant à diverses réponses cellulaires. Les mutations des gènes Ras sont courantes dans les cancers, faisant de Ras un point focal important de la recherche sur le cancer. Chez CymitQuimica, nous offrons une gamme de modulateurs de Ras pour soutenir vos recherches en biologie du cancer, transduction de signaux et développement thérapeutique.
154 produits trouvés pour "Ras"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
KRas G12C inhibitor 4
CAS :KRas G12C inhibitor 4 is a compound that inhibits KRas G12C.Formule :C33H38ClN7O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :600.15CCG-257081
CAS :CCG-257081 blocks Rho/MRTF/SRF pathway; prevents fibrosis in mice; useful in cancer and fibrosis research.Formule :C24H19ClF3N3O2Degré de pureté :99.60% - 99.94%Couleur et forme :SolidMasse moléculaire :473.87BI-2852
CAS :BI-2852: nanomolar affinity KRAS switch I/II pocket inhibitor; blocks signaling, halts KRAS mutant cell growth.Formule :C31H28N6O2Degré de pureté :97.77%Couleur et forme :SolidMasse moléculaire :516.59Ref: TM-T10533
1mg110,00€5mg261,00€10mg389,00€25mg643,00€50mg888,00€100mg1.224,00€1mL*10mM (DMSO)298,00€TH-Z827
CAS :TH-Z827 is a mutant-selective inhibitor targeting KRAS(G12D) with an IC50 of 2.4 μM, demonstrating specificity by not binding to KRAS(WT) or KRAS(G12C).Formule :C30H38N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :498.66CCG-232964
CAS :CCG-232964 is an orally active Rho/MRTF/SRF inhibitor that suppresses LPA-induced CTGF gene expression [1].Formule :C15H15ClN2O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :338.81KRAS G12C inhibitor 14
CAS :KRAS G12C inhibitor 14 is a potent KRAS G12C inhibitor with an IC 50 of 18 nM [1].Formule :C24H19ClF2N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :484.88RBC10
CAS :RBC10 inhibits the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-Formule :C24H25ClN2O2Degré de pureté :99.71%Couleur et forme :SolidMasse moléculaire :408.92Ref: TM-T24706
1mg33,00€2mg49,00€5mg75,00€10mg110,00€25mg245,00€50mg354,00€100mg515,00€200mg700,00€1mL*10mM (DMSO)81,00€KRas G12C inhibitor 1
CAS :KRas G12C inhibitor 1 is a compound that inhibits KRas G12C.Formule :C31H38N6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :542.67XRP44X
CAS :XRP44X (XRP 44X) is a potent inhibitor of Ras-Net (Elk-3) pathway.Formule :C21H21ClN4ODegré de pureté :99.67%Couleur et forme :SolidMasse moléculaire :380.87KRAS G12C inhibitor 5
CAS :KRAS G12C inhibitor 5 is a KRas G12C inhibitor.Formule :C32H37N7O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :551.68KRAS G12C inhibitor 32
CAS :KRAS G12C Inhibitor 32, an eight-membered heterocyclic compound with nitrogen, acts as a potent inhibitor of KRAS G12C [1].Formule :C29H30Cl3FN6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :635.94SOS1/KRAS-IN-1
CAS :SOS1/KRAS-IN-1 (Compound 2) serves as an inhibitor of SOS1/KRAS, with potential application in the study of diseases mediated by SOS1/KRAS [1].Formule :C24H26F3N5ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :457.49KRAS G12C inhibitor 17
CAS :KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor.Formule :C24H20ClF2N3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :471.88ML-099
CAS :ML-099 is a pan Ras-related GTPases activator that activates Rac1, Ras, GTP-binding protein (Rab7), Rab2A and cell division cycle 42.Formule :C14H13NO2SDegré de pureté :99.73%Couleur et forme :SolidMasse moléculaire :259.32Ref: TM-T22991
1mg46,00€2mg60,00€5mg90,00€10mg144,00€25mg289,00€50mg462,00€100mg672,00€1mL*10mM (DMSO)88,00€ARS-1323
CAS :ARS-1323 is the racemate of ARS-1620 and a mutant K-ras G12C inhibitor.Formule :C21H17ClF2N4O2Degré de pureté :99.53%Couleur et forme :SolidMasse moléculaire :430.84Ref: TM-T10375
2mg38,00€5mg56,00€10mg94,00€25mg129,00€50mg168,00€100mg235,00€200mg350,00€1mL*10mM (DMSO)63,00€pan-KRAS-IN-2
CAS :Pan-KRAS-IN-2 (compound 6) is a broad-spectrum KRAS inhibitor exhibiting potent activity with IC50 values of ≤10 nM against KRAS wild type and its mutants (G12DFormule :C34H34F2N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :584.66pan-KRAS-IN-3
CAS :Pan-KRAS-IN-3 (Example 84) is a pan-KRAS inhibitor suitable for cancer research [1].Formule :C33H32F3N5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :587.63KRAS G12C inhibitor 59
CAS :KRAS G12C Inhibitor 59 is a compound with anticancer properties.Formule :C32H39F6N7O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :715.69Rac1-IN-3
CAS :Rac1-IN-3 (Compound 2) is a Rac1 inhibitor exhibiting an inhibitory concentration 50 (IC50) of 46.1 μM [1].Formule :C21H23N7O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :405.45PROTAC KRAS G12C degrader-3
CAS :PROTAC KRAS G12C Degrader-3 (Comp 283) serves as a potent degrader of KRAS G12C, utilized in cancer research [1].Formule :C63H75ClN14O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1159.81KRAS G12D modulator-1
CAS :KRAS G12D modulator-1 (compound 6), a potent modulator of KRAS G12D, exhibits IC50 values ranging from 1-10 μM against NEA-G12D, PPI-G12D, and p ERK-AGS, and isFormule :C30H36FN5O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :549.64pan-KRAS-IN-4
CAS :Pan-KRAS-IN-4 (compound 5) is a potent KRAS inhibitor, demonstrating IC50 values of 0.37 nM for Kras G12C and 0.19 nM for Kras G12V [1].Formule :C36H34F2N6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :636.69KRAS G12C inhibitor 58
CAS :KRAS G12C inhibitor 58 is utilized in cancer research as an inhibitor of the KRAS G12C mutation [1].Formule :C51H64ClF4N9O8SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1074.62KRAS G12C inhibitor 13
CAS :KRAS G12C inhibitor 13 is a KRAS G12C inhibitor .Formule :C40H46F3N7O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :745.83BDP9066
CAS :BDP9066 is a potent and selective MRCK inhibitor, inhibits MRCKβ and MRCKα/β, and can be used for the prevention and treatment of skin cancer.Formule :C20H24N6Degré de pureté :98.18%Couleur et forme :SolidMasse moléculaire :348.44Ref: TM-T14521
1mg54,00€5mg114,00€10mg178,00€25mg409,00€50mg708,00€100mg1.224,00€500mg2.448,00€1mL*10mM (DMSO)126,00€Pan-RAS-IN-1
CAS :Pan-RAS-IN-1 is an inhibitor of pan-Ras. It disrupts the interaction of Ras proteins and their effectors.Formule :C36H41Cl2F3N6O2Degré de pureté :99.77%Couleur et forme :SolidMasse moléculaire :717.65Ref: TM-T16432
1mg75,00€2mg92,00€5mg137,00€10mg205,00€25mg416,00€50mg625,00€100mg888,00€500mg1.783,00€1mL*10mM (DMSO)210,00€INCB159020
CAS :INCB159020 is an orally active inhibitor of KRAS G12D, exhibiting a KRAS G12D SPR value of 2.2 nM. It demonstrates anti-tumor activity.Formule :C37H35ClFN7O2Couleur et forme :SolidMasse moléculaire :664.171SOS2 ligand 1
CAS :SOS2 ligand 1 (compound 2) is a selective ligand for son of sevenless 2 (SOS2), exhibiting a KD value of 4.6 µM.Formule :C19H21N5OCouleur et forme :SolidMasse moléculaire :335.403RGT-018
CAS :RGT-018 is a potent oral SOS1 inhibitor with antitumor properties. It exerts its anticancer activity by inhibiting KRAS activation, thereby hindering cancer cell proliferation.Formule :C27H24F3N7O2Couleur et forme :SolidMasse moléculaire :535.52pan-KRAS-IN-17
CAS :pan-KRAS-IN-17 (Example 34) is an inhibitor that targets multiple forms of the KRAS protein.Formule :C34H33F3N5O8PCouleur et forme :SolidMasse moléculaire :727.623KRAS inhibitor-31
CAS :KRAS inhibitor-31 (compound 33), a potent agent targeting KRAS, exhibits K D (SPR) values of 0.019 nM for KRas G12D, 0.019 nM for KRas G12C, and 0.096 nM for KRas G12V, illustrating its efficacy across these variants.Formule :C33H30F3N5O4Couleur et forme :SolidMasse moléculaire :617.62KRas G12C inhibitor 2
CAS :KRas G12C inhibitor 2 is a compound that inhibits KRas G12C.Formule :C32H37N7O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :567.68KRAS G12D inhibitor 26
CAS :KRAS G12D inhibitor 26 (Compound 64B) is an inhibitor of KRAS G12D with an IC50 ≤ 100 nM.Formule :C35H44ClFN8O2Degré de pureté :99.93%Couleur et forme :SolidMasse moléculaire :663.23Dorrigocin A
CAS :Dorrigocin A, an analog of Migrastatin, inhibits the carboxymethyltransferase involved in Ras processing, reversing the morphology of Ras-transformed NIH/3T3 cells. Dorrigocin A holds potential for research as an anticancer and anti-arthritis agent.Formule :C27H41NO8Couleur et forme :SolidMasse moléculaire :507.616ZCL279
CAS :ZCL279 is a small molecule modulator (SMM) that inhibits the interaction between CDC42 and intersectin (ITSN). At lower concentrations (<10 μM), ZCL279 activates Cdc42, a cytoplasmic small GTPase in the Ras superfamily, while at higher concentrations (<10 μM) it significantly inhibits it.Formule :C24H18N2O7S2Couleur et forme :SolidMasse moléculaire :510.539KRAS inhibitor-35
CAS :KRAS inhibitor-35 (compound 72) is a KRAS inhibitor with an IC50 of 2 nM, utilized in tumor research.Formule :C38H32F4N6O3SCouleur et forme :SolidMasse moléculaire :728.76XMU-MP-9
CAS :XMU-MP-9, a bifunctional compound, targets the C2 domain of Nedd4-1 and the allosteric site of K-Ras. It enhances the interaction and induces conformational changes within the Nedd4-1/K-Ras complex. Furthermore, XMU-MP-9 facilitates the ubiquitination and degradation of various K-Ras mutants and inhibits the proliferation of cells with these mutants. This compound is useful in cancer research.Formule :C19H13ClFN3OSCouleur et forme :SolidMasse moléculaire :385.84KRAS inhibitor-34
CAS :KRAS inhibitor-34 (compound 27) is a KRAS inhibitor with an IC50 of 6.4 nM and is utilized in oncological research.Formule :C43H41F3N6O3Couleur et forme :SolidMasse moléculaire :746.82SOF-436
CAS :SOF-436 is a KRAS inhibitor that can suppress SOS1-mediated KRAS nucleotide exchange (IC50 = 60 μM) and inhibit the interaction between KRAS and the effector protein RAF. SOF-436 is applicable to cancer research.Formule :C15H13F2NO4S2Couleur et forme :SolidMasse moléculaire :373.395KRAS inhibitor-37
CAS :KRAS inhibitor-37 (compound 2) is a potent inhibitor of KRAS, exhibiting low dissociation constants (KD) with various KRAS mutations: wild type (0.004 nM), G12D (0.041 nM), G12C (0.019 nM), and G12V (0.144 nM). This compound effectively inhibits cell proliferation, demonstrating half-maximal inhibitory concentrations (IC50) ranging from <2 nM to 14 nM in H358, SW620, and PANC08.13 cell lines. KRAS inhibitor-37 holds potential for cancer research applications.Formule :C32H33ClFN7O3Couleur et forme :SolidMasse moléculaire :618.10AM-001
CAS :AM-001 is a non-competitive inhibitor of Epac1, preventing the activation of its downstream effector Rap1 in cultured cells. This compound is utilized in research related to cardiac diseases.Formule :C24H16FN3OS2Couleur et forme :SolidMasse moléculaire :445.53J-104871
CAS :J-104871 (UNII-6137X5QNJF) is an FTase inhibitor that inhibits tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.Formule :C38H32N2O12Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :708.67ADT-1004
CAS :ADT-1004 is an inhibitor of RAS. It can be used for research involving Ras-mediated diseases.Formule :C33H36FN3O6Couleur et forme :SoildMasse moléculaire :589.65BMS-214662
CAS :BMS-214662 is a selective farnesyl transferase inhibitor with anti-tumor activity, used in research on pancreatic cancer, head and neck cancer, and lung cancer.Formule :C25H23N5O2S2Degré de pureté :99.58% - 99.58%Couleur et forme :SolidMasse moléculaire :489.61KRAS G12C inhibitor 15
CAS :KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor .Formule :C25H21ClF2N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :498.91PAT-IN-1
CAS :PAT-IN-1, a protein acyl transferases (PAT) inhibitor, competitively inhibits Erf2 autopalmitoylation (WO2017011518A1; compound 13) [1].Formule :C45H68N4OCouleur et forme :SolidMasse moléculaire :681.05(+)-Perillyl alcohol
CAS :(+)-Perillyl alcohol (0.25-1 mM) inhibits cell growth in SW480 cells. At a concentration of 1 mM and a duration of 24 hours, (+)-Perillyl alcohol increases the number of cells in the G0/G1 phase and reduces the number in the S phase in SW480 cells.Formule :C10H16OCouleur et forme :SolidMasse moléculaire :152.23KRAS inhibitor-32
CAS :KRAS inhibitor-32 (compound 139A) is a KRAS inhibitor utilized in cancer research.Formule :C29H35FN10OS2Couleur et forme :SolidMasse moléculaire :622.78pan-KRAS degrader 1
CAS :Pan-KRAS degrader 1 (Compound 1) is a broad-spectrum KRAS degrader, exhibiting an inhibitory constant Ki value of 25 nM against KRASG12V as determined by surface plasmon resonance (SPR). Additionally, this compound demonstrates antitumor activity.Formule :C22H26N8OSCouleur et forme :SolidMasse moléculaire :450.56Rho GTPase inhibitor 1
CAS :Rho GTPase inhibitor 1 (compound 7) is a potent inhibitor of Rho GTPase. It exhibits high affinity for Cdc42, Rac1, and RhoA, with dissociation constants (KDs) of 151 μM, 352 μM, and 232 μM, respectively. Additionally, Rho GTPase inhibitor 1 reduces cell migration in glioblastoma cell lines.Formule :C18H16N2OCouleur et forme :SolidMasse moléculaire :276.33Sosimerasib
CAS :Sosimerasib is an inhibitor of the kirsten rat sarcoma viral oncogene homolog (KRAS) and exhibits antitumor activity.
Formule :C36H39ClFN7O4Couleur et forme :SolidMasse moléculaire :688.191KRAS G12D inhibitor 28
CAS :KRAS G12D inhibitor 28 (Compound 1) is an inhibitor of KRAS G12D and can be utilized in cancer research.Formule :C35H32Cl2FN5OCouleur et forme :SolidMasse moléculaire :628.57KRAS inhibitor-41
CAS :KRAS inhibitor-41 is a KRAS inhibitor with an IC50 value of less than 0.01 μM for both KRAS G12D and KRAS G12V mutations. It effectively inhibits RAS mutant cell lines GP2D (KRAS-G12D) and SW620 (KRAS-G12V). KRAS inhibitor-41 is applicable for cancer research.Formule :C30H37FN10OSCouleur et forme :SolidMasse moléculaire :604.745KRAS inhibitor-8
CAS :KRAS inhibitor-8 is a potent KRAS G12C inhibitor.Formule :C26H24ClF4N5O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :565.95
